China Health Group (0673) Stock Price & Analysis

1 Followers

0673 Stock Chart & Stats

HK$0.26HK$0.00(0.00%)

At close: Nov 03 4:00 PM GMT+8

Day’s Range: HKD 0.26 - HKD 0.32
52-Week Range: HKD 0.25 - HKD 0.86
Previous Close: HKD 0.26
Volume: N/A
Average Volume (3M): 9,526
Market Cap: HKD 360.66M
Enterprise Value: HKD 711.52M
Total Cash (Recent Filing): HKD 21.95M
Total Debt (Recent Filing): HKD 4.59M
Price to Earnings (P/E): ―
Beta: -0.05
Next Earnings: Nov 27, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

2026 Revenue Rebound

The sharp 2026 revenue rebound shows that the company retained some ability to restore sales after a prolonged decline. If maintained, renewed top-line activity could provide a base for operating improvement, although the current scale remains well below 2022 levels.

Modest Leverage

Relatively modest leverage in periods with positive equity limits direct debt pressure and may preserve some financial flexibility. This provides a more stable starting point for recovery than a heavily indebted balance sheet, even though losses and equity weakness remain important constraints.

Narrower Losses

The reduction in losses during 2026 is an early indication that financial deterioration may have moderated from the prior year. A continued narrowing trend could improve capital preservation and eventually support operating stability, though profitability has not yet been restored.

Bears Say

Persistent Unprofitability

Recurring annual losses and a deeply negative 2026 margin indicate that the current business model is not converting revenue into sustainable earnings. Until margins improve materially, growth may not translate into stronger capital generation or dependable long-term shareholder returns.

Severe Cash Burn

Persistent negative operating cash flow means the company is not funding its activities through internally generated cash. The sharp 2026 outflow increases reliance on financing or balance-sheet support and reduces resilience if weak profitability continues over the coming quarters.

Negative Equity And Shrinking Assets

Negative equity signals accumulated financial strain and weakens the balance sheet’s capacity to absorb further losses. The concurrent decline in total assets suggests a shrinking operating footprint, which may limit resources available for rebuilding revenue and restoring profitability.

China Health Group News

China Health Group Revamps Board, Appoints New INED and CFO

An update from China Health Group ( ($HK:0673) ) is now available. China Health Group Limited has reshaped its senior governance structure with the resignation of independent non-executive director Ms.

2w ago0673

China Health Group details board and committee structure

China Health Group ( ($HK:0673) ) has issued an update. China Health Group Limited has announced the current composition of its board of directors, comprising three executive directors, two non-executive

2w ago0673

China Health Group Wins Unanimous Shareholder Backing at AGM

The latest announcement is out from China Health Group ( ($HK:0673) ). China Health Group Limited reported that all resolutions at its annual general meeting held in Shenzhen on 22

1M ago0673

China Health Group Calls AGM to Renew Board Mandates and Seek New Share-Issuance Authority

China Health Group ( ($HK:0673) ) just unveiled an update. China Health Group Limited has called its annual general meeting for 22 September 2026 in Shenzhen, where shareholders will review

3M ago0673

China Health Group Updates Bermuda Registered Office Address

The latest update is out from China Health Group ( ($HK:0673) ). China Health Group Limited has announced a change to the address of its registered office in Bermuda, effective

3M ago0673

China Health Group Appeals Mainland Court Ruling in Ongoing Litigation

The latest announcement is out from China Health Group ( ($HK:0673) ). China Health Group Limited has moved to challenge a civil judgment handed down by the Chengde Intermediate Court

3M ago0673

China Health Group corrects figures in 2026 annual results and restates loss

China Health Group ( ($HK:0673) ) has provided an update. China Health Group Limited issued a clarification to its previously released annual results for the year ended 31 March 2026,

4M ago0673

China Health Group Narrows Annual Loss Despite Higher Revenue

China Health Group ( ($HK:0673) ) has shared an announcement. China Health Group reported revenue of HK$41.1 million for the year ended 31 March 2026, a modest increase from HK$38.9

4M ago0673

China Health Group Sets Board Meeting to Approve Annual Results

An update from China Health Group ( ($HK:0673) ) is now available. China Health Group Limited has scheduled a board meeting for 30 June 2026 to review and approve the

4M ago0673

China Health Group Wins Partial Court Backing in RMB Loan Dispute

China Health Group ( ($HK:0673) ) has provided an update. China Health Group has received a civil judgment from the Chengde Intermediate People’s Court in Hebei over a loan dispute

5M ago0673

0673 FAQ

What was China Health Group’s price range in the past 12 months?

China Health Group lowest stock price was HK$0.25 and its highest was HK$0.86 in the past 12 months.

What is China Health Group’s market cap?

China Health Group’s market cap is HK$360.66M.

When is China Health Group’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were China Health Group’s earnings last quarter?

China Health Group released its earnings results on Jun 30, 2026. The company reported -HK$0.027 earnings per share for the quarter.

Is China Health Group overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does China Health Group pay dividends?

China Health Group does not currently pay dividends.

What is China Health Group’s EPS estimate?

China Health Group’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does China Health Group have?

China Health Group has 1,387,138,200 shares outstanding.

What happened to China Health Group’s price movement after its last earnings report?

China Health Group reported an EPS of -HK$0.027 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of China Health Group?

Currently, no hedge funds are holding shares in HK:0673

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description